Federal transportation testing is governed by applicable Department of Transportation rules, including 49 CFR Part 40 and the regulations for the employer’s transportation mode. Private employers may use separate workplace testing policies. Review the DOT Office of Drug and Alcohol Policy and Compliance and SAMHSA for federal information, then confirm the current requirements with the employer, designated employer representative, medical review officer, or qualified local counsel.
“DOT test” and “non-DOT test” are not interchangeable terms. They can involve different rules, forms, laboratories, drug panels, consequences, and recordkeeping requirements. A test may look similar at the collection site while carrying very different legal and employment consequences.
The first question should be simple: Which test is being run? Before providing a specimen, ask whether the test is DOT-regulated under 49 CFR or is being conducted under a private company policy. If the answer is unclear, request the testing authority and policy in writing.
What is a DOT drug or alcohol test?
A DOT test is conducted for an employer and employee covered by the federal transportation testing rules. The employee must perform safety-sensitive duties for a transportation employer subject to a DOT operating agency’s requirements. The applicable rules may differ by transportation mode, so the employer must identify the agency and rule set that applies.
DOT testing is not simply a test ordered by a company that happens to work in transportation. A private trucking, aviation, rail, transit, pipeline, or maritime company may have workers who are not covered by DOT testing rules. The employer’s industry alone does not determine coverage. The employee’s duties, employer status, and applicable operating regulations also matter.
DOT testing generally follows federally defined procedures for collection, laboratory testing, medical review, alcohol testing, reporting, return-to-duty requirements, and recordkeeping. An employer cannot replace those requirements with a less formal private process when the employee and test are covered by DOT rules.
What is a non-DOT test?
A non-DOT test is a workplace test conducted outside the DOT regulatory program. It is commonly based on an employer’s written policy, a collective bargaining agreement, an employment contract, a state requirement, or another lawful private process.
Non-DOT testing may apply to employees who are not subject to federal transportation testing. It may also be used in addition to a DOT test if the employer has a lawful, clearly communicated policy and follows applicable employment, privacy, disability, labor, and state requirements.
There is no single universal non-DOT procedure. The policy may define the testing circumstances, specimen type, substances included, cutoff levels, review process, notice requirements, and consequences. Because the policy controls, employees should obtain the current policy rather than assume that a non-DOT test follows Part 40.
How does 49 CFR differ from a private company policy?
49 CFR is a federal regulatory framework. It establishes mandatory procedures for covered DOT testing. A private policy is an employer-created document that must operate within applicable law and any contractual requirements.
The distinction affects more than the name printed on the order. Federal rules may control who can order a test, when a test is required, how a collector handles the specimen, how a laboratory reports results, when a medical review officer must contact the employee, and what steps follow a verified result.
A private policy may impose additional workplace rules, but it cannot be used to mislabel a test or bypass required DOT procedures. For example, an employer should not present a private test as a DOT test, or present a DOT result as though it were obtained solely under a private policy.
Who must take a DOT test?
DOT testing applies to covered employers and covered employees performing regulated safety-sensitive functions. Coverage depends on the applicable transportation agency and the employee’s role. Job titles can be misleading. Two employees with similar titles may fall under different testing requirements because their duties, employer, or operating authority differs.
Ask the employer or designated employer representative to identify:
- The DOT operating agency involved.
- The safety-sensitive position or duty that creates coverage.
- Whether the test is pre-employment, random, post-accident, reasonable suspicion, return-to-duty, follow-up, or another authorized test.
- The policy or regulation that authorizes the test.
Do not rely on a verbal statement that a position is “DOT related.” Request the specific basis for the test and confirm the answer locally when the classification is disputed.
Can a transportation employer run both DOT and non-DOT tests?
Yes, an employer may have both types of testing in its workplace, but the employer should keep the programs distinct. A DOT test must be identified and documented as a DOT test. A private test should be identified as non-DOT and handled under the employer’s policy.
Some employers use separate orders, forms, specimens, or laboratory arrangements for the two programs. Separation helps prevent a private result from being reported as a federal result and helps protect the integrity of the DOT record.
Employees should ask whether the employer is requesting one test or two tests. If two specimens are requested, ask which specimen belongs to which program, what policy authorizes the non-DOT test, and how each result will be used. The answers should be consistent with the written policy and applicable law.
Are the drug panels the same?
Not necessarily. A DOT drug test uses the substances and procedures required by the applicable federal rules. A non-DOT test may use a different panel selected by the employer or its testing provider.
A private panel may include substances that are not part of the applicable DOT panel, or it may omit substances included in the federal program. The specimen type may also differ. For example, an employer policy may address urine, oral fluid, hair, or another specimen type, while the DOT program has its own authorized requirements and implementation rules.
Do not assume that a result from one panel answers the question asked by the other program. Before testing, ask for the substances being tested and the specimen type. The collection site may be able to provide that information, but the employer or testing provider should be able to explain the authority for the order.
Does a DOT test use the same process as a non-DOT test?
The collection process may look similar, but the governing procedures may be different. DOT testing includes federally prescribed steps for identification, custody and control documentation, specimen handling, laboratory analysis, and result review.
DOT tests may involve a medical review officer who evaluates certain laboratory results and contacts the employee when required. The review is not a promise that a result will be changed. It is a required part of the federal process for evaluating relevant medical explanations and reporting the result under the governing rules.
Non-DOT testing may also use a medical review officer or a certified laboratory, but the employer’s policy determines the process unless a state or other legal requirement imposes additional rules. A private process may have different notices, review steps, appeal procedures, or reporting practices.
What happens after a verified DOT positive?
A verified positive DOT result can trigger federal consequences that are separate from the employer’s ordinary disciplinary policy. The employee may be removed from covered safety-sensitive duties and may need to complete the federal return-to-duty process before resuming those duties.
That process can include evaluation by a substance abuse professional, education or treatment recommendations, a return-to-duty test, and follow-up testing when required. The exact requirements depend on the circumstances and applicable regulations. A supervisor, employer, or collection site should not improvise the process.
An employee who receives a DOT violation should promptly ask for the written instructions, the name of the designated employer representative, and information about the required next step. Because deadlines and procedural rights may apply, confirm the current requirements with the employer, the assigned professional, and qualified local counsel when necessary.
What happens after a non-DOT positive?
The consequences of a non-DOT positive depend on the employer’s written policy and applicable law. Possible outcomes may include review by a medical professional, a chance to explain a lawful prescription, removal from a particular assignment, discipline, termination, or an opportunity to retest if the policy provides one.
A private positive does not automatically create a DOT violation. Similarly, a DOT negative does not necessarily satisfy every separate private-policy requirement if the employer lawfully ordered an additional test under its policy.
Employees should ask for the policy section that applies, the identity of the reviewing professional, the deadline to respond, and whether the specimen may be tested or reviewed again. Avoid assuming that a private policy contains the same protections or procedures as Part 40.
Can a prescription affect a DOT result?
A prescription or other lawful medication may be relevant to the medical review process, but it does not automatically determine the final result. The medical review officer evaluates the information under the applicable rules and may request documentation from the employee or the treating professional.
Employees should provide accurate information when contacted and should not send medical records to an employer unless instructed through an appropriate process. Ask the medical review officer what documentation is needed and where it should be sent.
Non-DOT policies may use a different review process. Some policies direct questions to a medical review officer, while others identify a human resources contact or another reviewer. The policy should explain how medication information is handled and who can receive it.
What records are kept for DOT and non-DOT tests?
DOT rules establish recordkeeping requirements for covered testing programs. Employers, laboratories, medical review officers, substance abuse professionals, and other program participants may have defined responsibilities for maintaining and disclosing records.
Non-DOT records are usually managed under the employer’s policy and applicable privacy, employment, labor, and state requirements. The retention period, access process, and disclosure rules may differ from the DOT program.
Ask who maintains the record, how to request a copy, how long it will be retained, and whether the record is part of a DOT file or a private personnel file. Keep copies of notices, forms, results, and correspondence received during the process.
How can an employee confirm which test is being run?
Use a written confirmation checklist before the collection whenever possible. Ask the employer or testing provider:
- Is this test DOT or non-DOT?
- If it is DOT, which operating agency and rule apply?
- What testing event is being used?
- What specimen type will be collected?
- What substances or alcohol testing procedures are included?
- Which policy or regulation authorizes the test?
- Who is the designated employer representative or policy contact?
- Who will review the result?
- How will the result be reported?
- What rights or deadlines apply if there is a non-negative or positive result?
If the answer changes between the employer, collection site, and testing provider, pause and request clarification. Do not assume that a generic chain-of-custody form identifies the governing program. The order, policy, and employer explanation should match.
What should employers do to avoid mixing the programs?
Employers should maintain separate written procedures for DOT and non-DOT testing. Training should explain which employees are covered, which events require testing, who may make a referral, and how results are handled.
Employers should also use clear labels, separate forms when appropriate, accurate notices, and properly trained collection and review personnel. A private policy should state when it applies and should not imply that every company employee is subject to DOT requirements.
Before launching or revising a program, the employer should review the current federal requirements, applicable state and local rules, contracts, collective bargaining obligations, and privacy considerations. The employer should confirm the details with qualified counsel or the relevant regulator instead of relying on an outdated template.
Which test should you rely on when the results conflict?
There is no universal answer because the purpose of each test may differ. A DOT result controls the federal transportation testing question when the test was properly conducted under the applicable DOT rules. A non-DOT result may control a separate employment-policy question if it was authorized and handled under the employer’s policy.
Conflicting results require a review of the orders, specimen types, collection dates, panels, laboratory reports, and governing policies. Ask the employer to identify the decision being made and the authority for that decision.
When a job action depends on a disputed result, seek timely professional advice. Confirm locally because state rules, employment agreements, and transportation-specific requirements can affect the available process.
What is the safest practical rule?
Never guess whether a test is DOT or non-DOT. Confirm the program before collection, read the applicable policy, ask who is responsible for reviewing the result, and keep records of the explanation you receive.
DOT testing is a regulated federal process. Non-DOT testing is a private or otherwise separate workplace process governed by the employer’s policy and applicable law. The names may sound similar, but the procedures and consequences can be different. When in doubt, contact the employer’s designated representative, review the federal guidance from the DOT Office of Drug and Alcohol Policy and Compliance, consult the available SAMHSA information, and confirm the current requirements with qualified local professionals.